title: Long-term consequences of early linear growth retardation (stunting) in Swedish children.
abstract: Linear growth retardation (stunting) is prevalent (10-80%) in developing countries. It takes place between 6 and 18 mo of age and can be characterized by the delayed onset of the childhood phase of growth. The objective of this work was to study the existence of stunting in early life and, when present, its lifelong effects on final height in a normal healthy population in a developed country. A total of 2432 children with longitudinal height data from birth to adulthood were analyzed. The series represents a normal healthy population-based sample of full-term children born around 1974 in Göteborg, Sweden. We found the incidence of stunting to be about 10% as indicated by delayed onset of the childhood phase of growth (>12 mo of age): 14% in boys and 8% in girls. In a multiple linear regression model, final height was described by length at 6 mo of age, age at onset of the childhood phase of growth, and age at peak height velocity during puberty. All three measures contributed significantly (p < 0.05) to final height with a total R2 of 0.33. A final height difference of 5.0 cm could be explained by abnormal onset of the childhood phase of growth in this normal population. The timing of the childhood onset of growth did not correlate with the timing of puberty. For the first time, we can conclude that stunting in early life is not only a problem in developing countries. Its importance on final height achieved is clearly shown, even after controlling for the timing of puberty.
authors.affiliation: Department of Paediatrics, Queen Mary Hospital, University of Hong Kong, SAR, People's Republic of China.
authors.forename: Y
authors.initials: Y
authors.lastname: Liu
authors.forename: K
authors.initials: K
authors.lastname: Albertsson-Wikland
authors.forename: J
authors.initials: J
authors.lastname: Karlberg
mesh_terms: D001827:Body Height; D002648:Child; D005260:Female; D006130:Growth Disorders / Q000453:epidemiology / Q000503:physiopathology*; D006801:Humans; D008297:Male; D012044:Regression Analysis; D013548:Sweden / Q000453:epidemiology